GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Suzhou Basecare Medical Corp Ltd (HKSE:02170) » Definitions » ROA %

Suzhou Basecare Medical (HKSE:02170) ROA % : -13.49% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Suzhou Basecare Medical ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Suzhou Basecare Medical's annualized Net Income for the quarter that ended in Dec. 2023 was HK$-285.1 Mil. Suzhou Basecare Medical's average Total Assets over the quarter that ended in Dec. 2023 was HK$2,112.7 Mil. Therefore, Suzhou Basecare Medical's annualized ROA % for the quarter that ended in Dec. 2023 was -13.49%.

The historical rank and industry rank for Suzhou Basecare Medical's ROA % or its related term are showing as below:

HKSE:02170' s ROA % Range Over the Past 10 Years
Min: -356.41   Med: -58.97   Max: -6.53
Current: -10.12

During the past 6 years, Suzhou Basecare Medical's highest ROA % was -6.53%. The lowest was -356.41%. And the median was -58.97%.

HKSE:02170's ROA % is ranked worse than
58.95% of 860 companies
in the Medical Devices & Instruments industry
Industry Median: -2.27 vs HKSE:02170: -10.12

Suzhou Basecare Medical ROA % Historical Data

The historical data trend for Suzhou Basecare Medical's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Basecare Medical ROA % Chart

Suzhou Basecare Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial -351.33 -356.41 -13.47 -6.53 -10.32

Suzhou Basecare Medical Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.22 -2.31 -11.04 -6.49 -13.49

Competitive Comparison of Suzhou Basecare Medical's ROA %

For the Medical Devices subindustry, Suzhou Basecare Medical's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Basecare Medical's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Suzhou Basecare Medical's ROA % distribution charts can be found below:

* The bar in red indicates where Suzhou Basecare Medical's ROA % falls into.



Suzhou Basecare Medical ROA % Calculation

Suzhou Basecare Medical's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-209.661/( (1987.594+2076.087)/ 2 )
=-209.661/2031.8405
=-10.32 %

Suzhou Basecare Medical's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-285.074/( (2149.248+2076.087)/ 2 )
=-285.074/2112.6675
=-13.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


Suzhou Basecare Medical  (HKSE:02170) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=-285.074/2112.6675
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-285.074 / 267.822)*(267.822 / 2112.6675)
=Net Margin %*Asset Turnover
=-106.44 %*0.1268
=-13.49 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Suzhou Basecare Medical ROA % Related Terms

Thank you for viewing the detailed overview of Suzhou Basecare Medical's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzhou Basecare Medical (HKSE:02170) Business Description

Traded in Other Exchanges
N/A
Address
BioBay, No. 218 Xinghu Street, Unit 101, Building A3, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000
Suzhou Basecare Medical Corp Ltd is engaged in providing genetic testing solutions for assisted human reproduction. The company generates revenues from Sales of testing kits, followed by Sales of testing devices and instruments. Basecare focuses on the assisted reproductive sector, such as pre-implantation genetic screening and diagnosis, non-invasive prenatal DNA testing, and chromosome abnormalities testing. It generates revenue from China.
Executives
Orbimed Capital Llc 2102 Investment manager
Lake Bleu Prime Healthcare Master Fund Limited 2201 Interest of corporation controlled by you
Orbimed Partners Master Fund Limited 2101 Beneficial owner
Dawn Capital Fund 2101 Beneficial owner
Dawn Capital Limited 2102 Investment manager
Hh Spr-xiv Cy Holdings Limited 2201 Interest of corporation controlled by you
Hh Spr-xiv Hk Holdings Limited 2101 Beneficial owner
Hh Spr-xiv Holdings L.p. 2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p. 2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd. 2102 Investment manager

Suzhou Basecare Medical (HKSE:02170) Headlines

No Headlines